You are here

Benzocaine Gel Toothache Dose-Response Study

Last updated on March 14, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Baltimore, Maryland, 21201 United States
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Toothache
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
12 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Males or females at least 12 years of age.

- Presence of spontaneous toothache pain in only one permanent tooth. Toothache pain is
due only to an open tooth cavity and only as a result of dental caries, loss of a
restoration or tooth fracture.

- To qualify for the study, the subject must have a rating of at least moderate pain on
the Dental Pain Scale (DPS) and a score of at least 50 mm on the Visual Analog Scale.
To be included in the moderate pain stratum, the subjects must have a rating of
moderate pain in the DPS and to be included in the severe pain stratum the subjects
must have a rating of severe pain in the DPS.

- Females who are neither pregnant, as verified by a urine-based pregnancy test, nor
breast-feeding.

- Female subjects of childbearing potential and those who are post-menopausal for less
than 2 years must be using a medically approved method of contraception (i.e., oral,
transdermal or implanted contraceptive devices, intrauterine device, diaphragm,
condom, abstinence, or surgical sterility).

- Subjects must be reliable, cooperative and of adequate intelligence to read and
understand the rating scales and other study instructions.

- Subjects must be able to read, comprehend, and sign the consent form. Minors will
provide assent to study participation if age appropriate. Parent/legal guardian must
be able to read, comprehend, and sign the informed consent form.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Presence of spontaneous toothache pain in a primary tooth. Presence of spontaneous
toothache pain in more than one tooth. Presence of an open tooth cavity in a tooth
adjacent to the painful tooth with the open tooth cavity.

- Presence of concomitant oral pain due to any other condition such as: soft-tissue
lesions (e.g., aphthous or traumatic ulcer, herpes labialis, acute necrotizing
ulcerative gingivitis); or multiple hard-tissue (e.g., carious) lesions; pain due to
other surgical procedures, injuries or dental surface sensitivity.

- Presence of a periodontal abscess as diagnosed from an X-ray or clinical examination
of the painful tooth.

- Presence of glucose-6-phosphate dehydrogenase (G6PD) deficiency.

- History of acute or chronic hemolytic anemia.

- History of sensitivity or allergy to benzocaine or other local anesthetic agents.

- Use of any short-acting oral or topical analgesic/ anesthetic product within 2 hours
of enrollment or any long-acting Rx or OTC analgesic product within 4 hours of
enrollment.

- Use of an investigational drug or participation in an investigational study within the
past 30 days.

- Previous participation in this study.

- Member or a relative of the study site staff or sponsor directly involved in the
study.

NCT00474175
Pfizer
Completed
Benzocaine Gel Toothache Dose-Response Study

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now